Login / Signup

A novel use of intermittent low dose dabigatran for maintenance of remission in livedoid vasculopathy.

Bandhala Rajan MAbhishek BhardwajJyotsna Naresh BhartiAkriti Agrawal
Published in: Dermatologic therapy (2021)
Keyphrases
  • low dose
  • atrial fibrillation
  • disease activity
  • high dose
  • high intensity
  • ulcerative colitis
  • rheumatoid arthritis
  • systemic lupus erythematosus